Board Meeting Intimation for Audited Results And Audit Report
30-Apr-2026 | Source : BSENatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2026 inter alia to consider and approve Audited Results and Audit Report
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
28-Apr-2026 | Source : BSEFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
| Sr. No. | Particulars | Details |
| 1 | Name of Company | Natural Biocon (India) Ltd |
| 2 | CIN NO. | L24299GJ1992PLC018210 |
| 3 | Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr) | 0.00 |
| 4 | Highest Credit Rating during the previous FY | NA |
| 4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
| 5 | Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework | BSE |
We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No
Name of the Company Secretary: Gopal Trivedi
Designation: Company Secretary and Compliance Officer
EmailId: naturalbioconindia@gmail.com
Designation: Company Secretary and Compliance Officer
EmailId: naturalbioconindia@gmail.com
Name of the Chief Financial Officer: Arunkumar Prajapati
Designation: Chief Financial Officer
EmailId: naturalbioconindia@gmail.com
Designation: Chief Financial Officer
EmailId: naturalbioconindia@gmail.com
Date: 28/04/2026
Note: In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Board Meeting Intimation for Audited Financial Result For The Quarter And Financial Year Ended On 31St March 2026 Along With The Auditors Report.
22-Apr-2026 | Source : BSENatural Biocon (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve Audited Financial Result for the Quarter and Financial Year Ended on 31st March 2026 along with the Auditors Report.
Corporate Actions
09 May 2026
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






